Danaher Corp. Stock
Danaher Corp. Stock
We can see a decrease in the price for Danaher Corp.. Compared to yesterday it has lost -€1.760 (-1.060%).
With 48 Buy predictions and not a single Sell prediction Danaher Corp. is an absolute favorite of our community.
With a target price of 214 € there is a positive potential of 29.68% for Danaher Corp. compared to the current price of 165.02 €.
Our community identified positive and negative aspects for Danaher Corp. stock for the coming years. 2 users see the criterium "Worthwhile Investment for the next years" as a plus for the Danaher Corp. stock. On the other hand our users think that "Debt" could be a problem in the future.
Pros and Cons of Danaher Corp. in the next few years
Pros
?
G***** c******* t* c**********
?
C******** o* t** e**********
?
M***** P*******
Cons
?
W********* I********* f** t** n*** y****
?
S********** s********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Danaher Corp. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Danaher Corp. | -1.060% | -1.056% | -5.753% | -14.208% | -14.891% | -26.819% | -8.070% |
| W.W. Grainger Inc. | -0.330% | -3.628% | -3.285% | 3.819% | 5.985% | 48.570% | 171.882% |
| Enovis Corp. | -1.490% | -4.673% | 9.091% | -42.697% | -10.526% | -58.197% | -82.383% |
| IDEX Corp. | -1.310% | -1.755% | -6.907% | -2.105% | 7.944% | -20.625% | -1.726% |
sharewise BeanCounterBot
The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
Last updated at 2025-04-26
Danaher Corp's current financial position shows:
Key findings: * Revenue remained relatively stable compared to the same quarter last year ($5.741 billion in Q2 2024) * Net profit decreased by 12.3% compared to Q2 2024 ($1.088 billion vs $1.242 billion) * Cash and cash equivalents decreased to $1.993 billion from $2.078 billion at the end of 2024
Overall financial trend: Mixed
Comments
Danaher (NYSE:DHR) had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $270.00 to $265.00. They now have a "buy" rating on the stock.
Show more
Ratings data for DHR provided by MarketBeat
Danaher (NYSE:DHR) had its price target raised by analysts at JPMorgan Chase & Co. from $270.00 to $275.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for DHR provided by MarketBeat
Danaher (NYSE:DHR) had its "buy" rating reaffirmed by analysts at Deutsche Bank Aktiengesellschaft.
Show more
Ratings data for DHR provided by MarketBeat
News
Here's Why Shares in Danaher Got Boosted Higher Today
Shares in biotechnology, life sciences, and diagnostics company Danaher (NYSE: DHR) rose by as much as 12.9% in early morning trading today. The move follows a well-received third-quarter earnings
